IN
Incyte
INCY·NASDAQWilmington DEFounded 19912,200 employees
Large CapbiotechPublicOncologyHematologyDermatology
Platform: JAK & Kinases
Market Cap
$14B
All Drugs
5
Clinical Trials
9
Failed / Terminated
3
FDA Approved
0
Stock Price & Catalysts (INCY)
Loading INCY stock data...
Drug Pipeline (5 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| INC-2432 | INC-2432 | Phase 2 | 1 | CD47 | FTDADHD | ||
| INC-1261 | INC-1261 | Phase 1/2 | 1 | PRMT5 | NMOSD | ||
| Capifutibatinib | INC-4967 | Phase 3 | 3 | PCSK9 | MigraineMCL | ||
| INC-5849 | INC-5849 | Phase 2 | 2 | PCSK9 | MMPsoriasis | ||
| INC-1582 | INC-1582 | Phase 1/2 | 2 | APOC3 | Heart FailureOvarian Ca |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (7)